Cargando…

Early Growth Response 3 (Egr3) Is Highly Over-Expressed in Non-Relapsing Prostate Cancer but Not in Relapsing Prostate Cancer

Members of the early growth response (EGR) family of transcription factors play diverse functions in response to many cellular stimuli, including growth, stress, and inflammation. Egr3 has gone relatively unstudied, but here through use of the SPECS (Strategic Partners for the Evaluation of Predicti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pio, Rebecca, Jia, Zhenyu, Baron, Veronique T., Mercola, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544741/ https://www.ncbi.nlm.nih.gov/pubmed/23342084 http://dx.doi.org/10.1371/journal.pone.0054096

Ejemplares similares

Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer
por: Baron, V T, et al.
Publicado: (2015)

Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse
por: Jia, Zhenyu, et al.
Publicado: (2012)

Correction: Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse
por: Jia, Zhenyu, et al.
Publicado: (2012)

Cavitary lung metastasis as relapse of prostate cancer
por: Polistina, G.E., et al.
Publicado: (2019)

Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells
por: Sauer, Lysann, et al.
Publicado: (2010)

Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer
por: Wei, Ziwei, et al.
Publicado: (2022)

RADIOTHERAPY OF PROSTATE CANCER: PRIMARY RADIOTHERAPY AND RADIOTHERAPY IN DISEASE RELAPSE
por: Antunac, Katarina
Publicado: (2019)

TGF-β mediated DNA methylation in prostate cancer
por: Lee, Chung, et al.
Publicado: (2012)

Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma
por: Argalácsová, Soňa, et al.
Publicado: (2023)

Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy
por: Hernandez, D., et al.
Publicado: (2015)

Survival Outcomes and Pattern of Relapse After SABR for Oligometastatic Prostate Cancer
por: Mercier, Carole, et al.
Publicado: (2022)

Combinatorial Ranking of Gene Sets to Predict Disease Relapse: The Retinoic Acid Pathway in Early Prostate Cancer
por: Nim, Hieu T., et al.
Publicado: (2017)

(68)Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy
por: Haidar, Mohamad, et al.
Publicado: (2022)

EGR1 Regulates Angiogenic and Osteoclastogenic Factors in Prostate Cancer and Promotes Metastasis
por: Li, Lechen, et al.
Publicado: (2019)

Relapse of prostate cancer from the viewpoint of total gland volume kinetics theory
por: Watanabe, Hiroki
Publicado: (2015)

Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner
por: WANG, Zhenyu, et al.
Publicado: (2022)

Role of the Adjacent Stroma Cells in Prostate Cancer Development and Progression: Synergy between TGF-β and IGF Signaling
por: Lee, Chung, et al.
Publicado: (2014)

Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse
por: Fraser, Michael, et al.
Publicado: (2021)

The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer
por: Tisseverasinghe, Steven A., et al.
Publicado: (2018)

Post‐treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer
por: Gumulec, Jaromir, et al.
Publicado: (2018)

Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients
por: Cailleteau, Axel, et al.
Publicado: (2021)

The Prognostic Value of Liquid Biopsies for Benefit of Salvage Radiotherapy in Relapsed Oligometastatic Prostate Cancer
por: Bogdanova, Natalia V., et al.
Publicado: (2022)

An Accurate Prostate Cancer Prognosticator Using a Seven-Gene Signature Plus Gleason Score and Taking Cell Type Heterogeneity into Account
por: Chen, Xin, et al.
Publicado: (2012)

The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma
por: Chen, Xin, et al.
Publicado: (2015)

Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy
por: Janowitz, Tobias, et al.
Publicado: (2015)

Intensity of stromal changes is associated with tumor relapse in clinically advanced prostate cancer after castration therapy
por: Wu, Jian-Ping, et al.
Publicado: (2014)

Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip
por: Arora, Shilpi, et al.
Publicado: (2008)

Early growth response 2 and Egr3 are unique regulators in immune system
por: Taefehshokr, Sina, et al.
Publicado: (2017)

Genetic Evidence for the Association between the Early Growth Response 3 (EGR3) Gene and Schizophrenia
por: Zhang, Rui, et al.
Publicado: (2012)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Efficacy of Alternative Antiandrogen Therapy for Prostate Cancer That Relapsed after Initial Maximum Androgen Blockade
por: Choi, Joon Il, et al.
Publicado: (2011)

Clinical Indications of (11)C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
por: Picchio, Maria, et al.
Publicado: (2012)

New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones
por: Schally, Andrew V, et al.
Publicado: (2015)

Egr2 and Egr3 are the unique regulators for systemic autoimmunity
por: Sumitomo, Shuji, et al.
Publicado: (2013)

Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma
por: Calogero, Antonella, et al.
Publicado: (2004)

Risk Factors for Relapse in Acute Bacterial Prostatitis: the Impact of Antibiotic Regimens
por: Marquez-Algaba, Ester, et al.
Publicado: (2021)

Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapse
por: Lorenzo, Guillermo, et al.
Publicado: (2022)

Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients
por: Willder, J M, et al.
Publicado: (2013)

Corrigendum to “Relapse of prostate cancer from the viewpoint of total gland volume kinetics theory” by Hiroki Watanabe
por: Watanabe, Hiroki
Publicado: (2016)

Interpretation of 11C–choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer
por: Matti, A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7qcgfukvqj9q1ah33nekg7uh98